BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 33939203)

  • 1. Dysfunction of RAB39B-Mediated Vesicular Trafficking in Lewy Body Diseases.
    Koss DJ; Campesan S; Giorgini F; Outeiro TF
    Mov Disord; 2021 Aug; 36(8):1744-1758. PubMed ID: 33939203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodies.
    Koss DJ; Bondarevaite O; Adams S; Leite M; Giorgini F; Attems J; Outeiro TF
    Brain Pathol; 2021 Jan; 31(1):120-132. PubMed ID: 32762091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology.
    Wilson GR; Sim JC; McLean C; Giannandrea M; Galea CA; Riseley JR; Stephenson SE; Fitzpatrick E; Haas SA; Pope K; Hogan KJ; Gregg RG; Bromhead CJ; Wargowski DS; Lawrence CH; James PA; Churchyard A; Gao Y; Phelan DG; Gillies G; Salce N; Stanford L; Marsh AP; Mignogna ML; Hayflick SJ; Leventer RJ; Delatycki MB; Mellick GD; Kalscheuer VM; D'Adamo P; Bahlo M; Amor DJ; Lockhart PJ
    Am J Hum Genet; 2014 Dec; 95(6):729-35. PubMed ID: 25434005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies.
    Hodges K; Brewer SS; Labbé C; Soto-Ortolaza AI; Walton RL; Strongosky AJ; Uitti RJ; van Gerpen JA; Ertekin-Taner N; Kantarci K; Lowe VJ; Parisi JE; Savica R; Graff-Radford J; Jones DT; Knopman DS; Petersen RC; Murray ME; Graff-Radford NR; Ferman TJ; Dickson DW; Wszolek ZK; Boeve BF; Ross OA; Lorenzo-Betancor O
    Neurobiol Aging; 2016 Sep; 45():107-108. PubMed ID: 27459931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of Rab GTPases in the pathogenesis of Parkinson's disease.
    Gao Y; Wilson GR; Stephenson SEM; Bozaoglu K; Farrer MJ; Lockhart PJ
    Mov Disord; 2018 Feb; 33(2):196-207. PubMed ID: 29315801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Neuropathological Features Associated With Loss of RAB39B.
    Gao Y; Martínez-Cerdeño V; Hogan KJ; McLean CA; Lockhart PJ
    Mov Disord; 2020 Apr; 35(4):687-693. PubMed ID: 31951675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAB39B's role in membrane traffic, autophagy, and associated neuropathology.
    Tang BL
    J Cell Physiol; 2021 Mar; 236(3):1579-1592. PubMed ID: 32761840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel RAB39B loss-of-function mutation in patient with typical early-onset Parkinson's disease.
    Jacobson JR; Piat C; Aksamit AJ; Patane' G; Ross OA; Savica R
    Parkinsonism Relat Disord; 2024 Jun; 123():106038. PubMed ID: 38503262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology.
    Eisbach SE; Outeiro TF
    J Mol Med (Berl); 2013 Jun; 91(6):693-703. PubMed ID: 23616088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabs, Membrane Dynamics, and Parkinson's Disease.
    Tang BL
    J Cell Physiol; 2017 Jul; 232(7):1626-1633. PubMed ID: 27925204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of RAB39B mutations in early-onset and familial Parkinson's disease in a Taiwanese cohort.
    Lin HH; Wu RM; Lin HI; Chen ML; Tai CH; Lin CH
    Neurobiol Aging; 2017 Feb; 50():169.e3-169.e4. PubMed ID: 27838047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Cholesterol in α-Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease.
    García-Sanz P; M F G Aerts J; Moratalla R
    Mov Disord; 2021 May; 36(5):1070-1085. PubMed ID: 33219714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological roles of α-synuclein in neurological disorders.
    Vekrellis K; Xilouri M; Emmanouilidou E; Rideout HJ; Stefanis L
    Lancet Neurol; 2011 Nov; 10(11):1015-25. PubMed ID: 22014436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intellectual disability protein RAB39B selectively regulates GluA2 trafficking to determine synaptic AMPAR composition.
    Mignogna ML; Giannandrea M; Gurgone A; Fanelli F; Raimondi F; Mapelli L; Bassani S; Fang H; Van Anken E; Alessio M; Passafaro M; Gatti S; Esteban JA; Huganir R; D'Adamo P
    Nat Commun; 2015 Mar; 6():6504. PubMed ID: 25784538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function.
    Kim MJ; Jeon S; Burbulla LF; Krainc D
    Hum Mol Genet; 2018 Jun; 27(11):1972-1988. PubMed ID: 29579237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease.
    Zhou W; Milder JB; Freed CR
    J Biol Chem; 2008 Apr; 283(15):9863-70. PubMed ID: 18238775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of the RAB39B gene in Chinese Han patients with Parkinson's disease.
    Yuan L; Deng X; Song Z; Yang Z; Ni B; Chen Y; Deng H
    Neurobiol Aging; 2015 Oct; 36(10):2907.e11-2. PubMed ID: 26163985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked Parkinsonism with Intellectual Disability caused by novel mutations and somatic mosaicism in RAB39B gene.
    Ciammola A; Carrera P; Di Fonzo A; Sassone J; Villa R; Poletti B; Ferrari M; Girotti F; Monfrini E; Buongarzone G; Silani V; Cinnante CM; Mignogna ML; D'Adamo P; Bonati MT
    Parkinsonism Relat Disord; 2017 Nov; 44():142-146. PubMed ID: 28851564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and Toxicity.
    Gonçalves SA; Macedo D; Raquel H; Simões PD; Giorgini F; Ramalho JS; Barral DC; Ferreira Moita L; Outeiro TF
    PLoS Genet; 2016 Apr; 12(4):e1005995. PubMed ID: 27123591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly.
    Giannandrea M; Bianchi V; Mignogna ML; Sirri A; Carrabino S; D'Elia E; Vecellio M; Russo S; Cogliati F; Larizza L; Ropers HH; Tzschach A; Kalscheuer V; Oehl-Jaschkowitz B; Skinner C; Schwartz CE; Gecz J; Van Esch H; Raynaud M; Chelly J; de Brouwer AP; Toniolo D; D'Adamo P
    Am J Hum Genet; 2010 Feb; 86(2):185-95. PubMed ID: 20159109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.